| __timestamp | Genmab A/S | Intra-Cellular Therapies, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 79529000 | 10337679 |
| Thursday, January 1, 2015 | 91224000 | 18187286 |
| Friday, January 1, 2016 | 102413000 | 24758063 |
| Sunday, January 1, 2017 | 146987000 | 23666957 |
| Monday, January 1, 2018 | 213695000 | 30099855 |
| Tuesday, January 1, 2019 | 342000000 | 64947625 |
| Wednesday, January 1, 2020 | 661000000 | 186363444 |
| Friday, January 1, 2021 | 1283000000 | 272611040 |
| Saturday, January 1, 2022 | 2676000000 | 358782000 |
| Sunday, January 1, 2023 | 3297000000 | 409864000 |
| Monday, January 1, 2024 | 3790000000 |
Unleashing insights
In the ever-evolving biotech industry, effective cost management is crucial for sustaining growth and innovation. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Genmab A/S and Intra-Cellular Therapies, Inc. over the past decade. From 2014 to 2023, Genmab A/S witnessed a staggering 4,000% increase in SG&A expenses, reflecting its aggressive expansion and strategic investments. In contrast, Intra-Cellular Therapies, Inc. experienced a more modest rise of approximately 3,900%, indicating a steady yet cautious approach to scaling operations.
The data highlights a pivotal trend: as these companies grow, so do their operational costs, underscoring the importance of balancing innovation with financial prudence. This insight is invaluable for investors and stakeholders aiming to understand the financial dynamics of leading biotech firms in a competitive landscape.
Breaking Down SG&A Expenses: Johnson & Johnson vs Intra-Cellular Therapies, Inc.
SG&A Efficiency Analysis: Comparing Novartis AG and Intra-Cellular Therapies, Inc.
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Intra-Cellular Therapies, Inc. Trends and Insights
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs Intra-Cellular Therapies, Inc.
Breaking Down SG&A Expenses: Genmab A/S vs Madrigal Pharmaceuticals, Inc.
Genmab A/S and Pharming Group N.V.: SG&A Spending Patterns Compared
Genmab A/S or Jazz Pharmaceuticals plc: Who Manages SG&A Costs Better?
Genmab A/S or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?
Intra-Cellular Therapies, Inc. and Dr. Reddy's Laboratories Limited: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Intra-Cellular Therapies, Inc. and Catalent, Inc.
Intra-Cellular Therapies, Inc. vs Ionis Pharmaceuticals, Inc.: SG&A Expense Trends
Intra-Cellular Therapies, Inc. or Amphastar Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?